Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,017 | 216 | 90.3% |
| Travel and Lodging | $400.60 | 2 | 7.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $123.44 | 1 | 2.2% |
| Education | $13.26 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $611.73 | 12 | $0 (2020) |
| Medtronic, Inc. | $522.24 | 6 | $0 (2024) |
| Amgen Inc. | $446.02 | 17 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $435.57 | 35 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $399.80 | 23 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $382.52 | 16 | $0 (2024) |
| Boston Scientific Corporation | $345.64 | 7 | $0 (2023) |
| PFIZER INC. | $266.38 | 17 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $262.07 | 13 | $0 (2024) |
| Abbott Laboratories | $235.13 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $651.45 | 20 | Medtronic, Inc. ($181.64) |
| 2023 | $1,028 | 45 | Medtronic, Inc. ($340.60) |
| 2022 | $508.38 | 26 | Abbott Laboratories ($126.08) |
| 2021 | $277.77 | 15 | Boehringer Ingelheim Pharmaceuticals, Inc. ($76.58) |
| 2020 | $393.83 | 10 | Boston Scientific Corporation ($164.45) |
| 2019 | $829.11 | 35 | Amgen Inc. ($214.42) |
| 2018 | $1,059 | 44 | PORTOLA PHARMACEUTICALS, INC. ($172.97) |
| 2017 | $807.64 | 25 | Medtronic Vascular, Inc. ($460.71) |
All Payment Transactions
220 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.23 | General |
| Category: Cardiovascular | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $111.44 | General |
| 11/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.82 | General |
| 10/15/2024 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/04/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/07/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $79.84 | General |
| Category: Stents | ||||||
| 08/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $85.04 | General |
| Category: Transcatheter Heart Valves | ||||||
| 06/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/03/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.25 | General |
| Category: Cardiovascular | ||||||
| 04/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.90 | General |
| Category: Cardiovascular | ||||||
| 04/08/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: DIABETES | ||||||
| 02/15/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/06/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/29/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/18/2024 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $101.80 | General |
| Category: Stents | ||||||
| 12/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: DIABETES | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2023 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/02/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/16/2023 | Medtronic, Inc. | COREVALVE EVOLUT R (Device) | Food and Beverage | In-kind items and services | $97.40 | General |
| Category: Transcatheter Valve Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 4,475 | 5,779 | $657,052 | $159,309 |
| 2022 | 25 | 3,551 | 4,217 | $638,525 | $188,872 |
| 2021 | 26 | 2,904 | 3,274 | $540,547 | $192,076 |
| 2020 | 33 | 3,733 | 4,369 | $649,592 | $216,135 |
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 611 | 685 | $241,213 | $58,897 | 24.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,692 | 3,793 | $117,583 | $22,265 | 18.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 105 | 105 | $58,485 | $15,343 | 26.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 111 | 210 | $40,591 | $13,109 | 32.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 62 | $33,371 | $8,062 | 24.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 63 | $23,121 | $6,286 | 27.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $20,700 | $5,114 | 24.7% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 11 | 11 | $17,678 | $4,749 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 62 | $15,500 | $4,215 | 27.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 79 | 79 | $15,148 | $4,112 | 27.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 21 | 21 | $16,869 | $3,869 | 22.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 408 | 424 | $19,061 | $3,818 | 20.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 39 | $10,846 | $3,639 | 33.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 24 | $11,928 | $2,653 | 22.2% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 12 | $7,838 | $1,254 | 16.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 43 | 43 | $1,505 | $415.31 | 27.6% |
| 93225 | Electrocardiogram (ecg) 2-day continuous | Office | 2023 | 26 | 26 | $1,400 | $349.51 | 25.0% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 25 | 25 | $1,291 | $347.16 | 26.9% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 14 | 14 | $982.00 | $280.47 | 28.6% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 14 | 14 | $952.00 | $255.88 | 26.9% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 11 | 11 | $737.00 | $203.29 | 27.6% |
| 93270 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | Office | 2023 | 11 | 11 | $253.00 | $71.50 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 636 | 782 | $219,922 | $68,388 | 31.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 179 | 180 | $88,760 | $25,917 | 29.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 109 | 225 | $36,755 | $12,534 | 34.1% |
About Dr. Randolph Renzi, MD
Dr. Randolph Renzi, MD is a Interventional Cardiology healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275512550.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Randolph Renzi, MD has received a total of $5,555 in payments from pharmaceutical and medical device companies, with $651.45 received in 2024. These payments were reported across 220 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,017).
As a Medicare-enrolled provider, Renzi has provided services to 14,663 Medicare beneficiaries, totaling 17,639 services with total Medicare billing of $756,391. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Interventional Cardiology
- Location Winchester, VA
- Active Since 01/13/2006
- Last Updated 12/07/2022
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1275512550
Products in Payments
- ClosureFast (Device) $441.20
- XARELTO (Drug) $382.52
- ELIQUIS (Drug) $350.15
- Repatha (Biological) $302.74
- JARDIANCE (Drug) $296.98
- COREVALVE EVOLUT R (Device) $290.87
- ENTRESTO (Drug) $280.94
- ONYX FRONTIER (Device) $231.37
- LifeVest (Device) $224.24
- WATCHMAN (Device) $178.29
- BRILINTA (Drug) $158.70
- LEQVIO (Drug) $154.63
- ANDEXXA (Drug) $146.07
- Corlanor (Drug) $143.28
- Impella (Device) $141.80
- GENERAL - STRUCTURAL HEART (Device) $136.99
- NEXLIZET (Drug) $125.00
- NONE (Drug) $123.44
- SAPIEN 3 Ultra RESILIA (Device) $108.09
- ENSITE PRECISION (Device) $106.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Winchester
Daniel Reese, Md, MD
Interventional Cardiology — Payments: $10,030
Dr. Neal Gaither, Md, MD
Interventional Cardiology — Payments: $8,969
Sumeet Lall
Interventional Cardiology — Payments: $5,218
Ather Anis, M.d, M.D
Interventional Cardiology — Payments: $2,216